Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 4 boards, counting each seat separately. Longest: Embecta Corp., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
BioMarin Pharmaceutical Inc. June 2, 202698.0%
-
Henry Schein Inc. May 22, 202593.9%
-
BioMarin Pharmaceutical Inc. May 20, 202598.4%
-
Embecta Corp. February 12, 202598.9%
-
BioMarin Pharmaceutical Inc. May 21, 202497.6%
-
BioMarin Pharmaceutical Inc. May 23, 202395.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 12, 2026 | Embecta Corp. | Open-market purchase | +45,000 | $4.97 | $223,650 |
| Jun 22, 2026 | Seaport Therapeutics Inc. | Open-market purchase | +13,000 | $18.14 | $235,820 |
| Jun 2, 2026 | BioMarin Pharmaceutical Inc. | Grant or award | +7,490 | — | — |
| Mar 6, 2026 | Henry Schein Inc. | Grant or award | +2,577 | — | — |
| Feb 11, 2026 | Embecta Corp. | Grant or award | +22,841 | — | — |
| May 20, 2025 | BioMarin Pharmaceutical Inc. | Grant or award | +6,650 | — | — |
| Mar 4, 2025 | Henry Schein Inc. | Grant or award | +2,844 | — | — |
| Feb 12, 2025 | Embecta Corp. | Grant or award | +13,839 | — | — |
| May 21, 2024 | BioMarin Pharmaceutical Inc. | Grant or award | +4,720 | — | — |
| Feb 7, 2024 | Embecta Corp. | Grant or award | +11,455 | — | — |
| May 23, 2023 | BioMarin Pharmaceutical Inc. | Grant or award | +4,190 | — | — |
| Feb 9, 2023 | Embecta Corp. | Grant or award | +6,979 | — | — |
Questions about Robert J. Hombach
What boards is Robert J. Hombach on?
Robert J. Hombach sits on the boards of BioMarin Pharmaceutical Inc., Embecta Corp., Henry Schein Inc. and Seaport Therapeutics Inc.
How long has Robert J. Hombach served on boards?
Our records show at least 10 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.